1. 313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms. (9th November 2020) Authors: Patel, Manish; Luke, Jason; Hamilton, Erika; Chmielowski, Bartosz; Blumenschein, George; Kindler, Hedy; Bahadur, Shakeela; Santa-Maria, Cesar; Koucheki, Janine; Sun, Jichao; Kaul, Sanjeev; Chen, Francine; Zhang, Xiaoyu; Muth, John; Kaminker, Patrick; Moore, Paul; Sumrow, Bradley; Ulahannan, Susanna Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms. (9th November 2020) Authors: Patel, Manish; Luke, Jason; Hamilton, Erika; Chmielowski, Bartosz; Blumenschein, George; Kindler, Hedy; Bahadur, Shakeela; Santa-Maria, Cesar; Koucheki, Janine; Sun, Jichao; Kaul, Sanjeev; Chen, Francine; Zhang, Xiaoyu; Muth, John; Kaminker, Patrick; Moore, Paul; Sumrow, Bradley; Ulahannan, Susanna Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples. (10th December 2020) Authors: Berezhnoy, Alexey; Shah, Kalpana; Liu, Daorong; Lung, Peter; Long, Vatana; Stahl, Kurt; Smith, Douglas; Chen, Francine; Li, Hua; Li, Jonathan; Alderson, Ralph; Ciccarone, Valentina; Tamura, James; Bonvini, Ezio; Diedrich, Gundo; Moore, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples. (9th November 2020) Authors: Berezhnoy, Alexey; Shah, Kalpana; Liu, Daorong; Lung, Peter; Long, Vatana; Stahl, Kurt; Smith, Douglas; Chen, Francine; Li, Hua; Li, Jonathan; Alderson, Ralph; Ciccarone, Valentina; Tamura, James; Bonvini, Ezio; Diedrich, Gundo; Moore, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer. Issue 2 (December 2015) Authors: Urba, Walter; Chmielowski, Bartosz; Loo, Deryk; Baughman, Jan; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Rizvi, Naiyer Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer. (4th November 2015) Authors: Urba, Walter; Chmielowski, Bartosz; Loo, Deryk; Baughman, Jan; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Rizvi, Naiyer Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer. Issue 2 (December 2015) Authors: Baughman, Jan; Loo, Deryk; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer. (4th November 2015) Authors: Baughman, Jan; Loo, Deryk; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3. Issue 2 (December 2015) Authors: Powderly, John; Cote, Gregory; Flaherty, Keith; Szmulewitz, Russell; Ribas, Antoni; Weber, Jeffrey; Loo, Deryk; Baughman, Jan; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger; Burris, Howard; Chmielowski, Bartosz Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3. (4th November 2015) Authors: Powderly, John; Cote, Gregory; Flaherty, Keith; Szmulewitz, Russell Z; Ribas, Antoni; Weber, Jeffrey; Loo, Deryk; Baughman, Jan; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger; Burris, Howard; Chmielowski, Bartosz Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗